Stay updated on Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page.

Latest updates to the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page
- Check4 days agoChange DetectedNo material changes to enrollment status or primary study details between the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check39 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various proteins and antibodies related to renal cell carcinoma. Notably, previous mentions of specific antineoplastic agents and molecular mechanisms have been removed.SummaryDifference2%

Stay in the know with updates to Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD1 Therapy in Metastatic Renal Cell Cancer Clinical Trial page.